List of Tables
Table 1. Global Psychiatric Long-acting Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Psychiatric Long-acting Injection Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Psychiatric Long-acting Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Psychiatric Long-acting Injection Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Psychiatric Long-acting Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Psychiatric Long-acting Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Psychiatric Long-acting Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Psychiatric Long-acting Injection Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Psychiatric Long-acting Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Psychiatric Long-acting Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Psychiatric Long-acting Injection, Product Type & Application
Table 12. Global Key Manufacturers of Psychiatric Long-acting Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Psychiatric Long-acting Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychiatric Long-acting Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Psychiatric Long-acting Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Psychiatric Long-acting Injection Sales by Region (2019-2024) & (K Units)
Table 18. Global Psychiatric Long-acting Injection Sales Market Share by Region (2019-2024)
Table 19. Global Psychiatric Long-acting Injection Sales by Region (2025-2030) & (K Units)
Table 20. Global Psychiatric Long-acting Injection Sales Market Share by Region (2025-2030)
Table 21. Global Psychiatric Long-acting Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Psychiatric Long-acting Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Psychiatric Long-acting Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Psychiatric Long-acting Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Psychiatric Long-acting Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Psychiatric Long-acting Injection Sales by Country (2019-2024) & (K Units)
Table 27. North America Psychiatric Long-acting Injection Sales by Country (2025-2030) & (K Units)
Table 28. North America Psychiatric Long-acting Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Psychiatric Long-acting Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Psychiatric Long-acting Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Psychiatric Long-acting Injection Sales by Country (2019-2024) & (K Units)
Table 32. Europe Psychiatric Long-acting Injection Sales by Country (2025-2030) & (K Units)
Table 33. Europe Psychiatric Long-acting Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Psychiatric Long-acting Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Psychiatric Long-acting Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Psychiatric Long-acting Injection Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Psychiatric Long-acting Injection Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Psychiatric Long-acting Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Psychiatric Long-acting Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Psychiatric Long-acting Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Psychiatric Long-acting Injection Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Psychiatric Long-acting Injection Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Psychiatric Long-acting Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Psychiatric Long-acting Injection Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Psychiatric Long-acting Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Psychiatric Long-acting Injection Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Psychiatric Long-acting Injection Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Psychiatric Long-acting Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Psychiatric Long-acting Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Psychiatric Long-acting Injection Sales (K Units) by Type (2019-2024)
Table 51. Global Psychiatric Long-acting Injection Sales (K Units) by Type (2025-2030)
Table 52. Global Psychiatric Long-acting Injection Sales Market Share by Type (2019-2024)
Table 53. Global Psychiatric Long-acting Injection Sales Market Share by Type (2025-2030)
Table 54. Global Psychiatric Long-acting Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Psychiatric Long-acting Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Psychiatric Long-acting Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Psychiatric Long-acting Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Psychiatric Long-acting Injection Price (US$/Unit) by Type (2019-2024)
Table 59. Global Psychiatric Long-acting Injection Price (US$/Unit) by Type (2025-2030)
Table 60. Global Psychiatric Long-acting Injection Sales (K Units) by Application (2019-2024)
Table 61. Global Psychiatric Long-acting Injection Sales (K Units) by Application (2025-2030)
Table 62. Global Psychiatric Long-acting Injection Sales Market Share by Application (2019-2024)
Table 63. Global Psychiatric Long-acting Injection Sales Market Share by Application (2025-2030)
Table 64. Global Psychiatric Long-acting Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Psychiatric Long-acting Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Psychiatric Long-acting Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Psychiatric Long-acting Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Psychiatric Long-acting Injection Price (US$/Unit) by Application (2019-2024)
Table 69. Global Psychiatric Long-acting Injection Price (US$/Unit) by Application (2025-2030)
Table 70. Oakwood Labs Company Information
Table 71. Oakwood Labs Description and Business Overview
Table 72. Oakwood Labs Psychiatric Long-acting Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Oakwood Labs Psychiatric Long-acting Injection Product
Table 74. Oakwood Labs Recent Developments/Updates
Table 75. Teva Company Information
Table 76. Teva Description and Business Overview
Table 77. Teva Psychiatric Long-acting Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Teva Psychiatric Long-acting Injection Product
Table 79. Teva Recent Developments/Updates
Table 80. MedinCell Company Information
Table 81. MedinCell Description and Business Overview
Table 82. MedinCell Psychiatric Long-acting Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. MedinCell Psychiatric Long-acting Injection Product
Table 84. MedinCell Recent Developments/Updates
Table 85. Janssen Company Information
Table 86. Janssen Description and Business Overview
Table 87. Janssen Psychiatric Long-acting Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Janssen Psychiatric Long-acting Injection Product
Table 89. Janssen Recent Developments/Updates
Table 90. Otsuka America Pharmaceutical, Inc. Company Information
Table 91. Otsuka America Pharmaceutical, Inc. Description and Business Overview
Table 92. Otsuka America Pharmaceutical, Inc. Psychiatric Long-acting Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Otsuka America Pharmaceutical, Inc. Psychiatric Long-acting Injection Product
Table 94. Otsuka America Pharmaceutical, Inc. Recent Developments/Updates
Table 95. Lundbeck Company Information
Table 96. Lundbeck Description and Business Overview
Table 97. Lundbeck Psychiatric Long-acting Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Lundbeck Psychiatric Long-acting Injection Product
Table 99. Lundbeck Recent Developments/Updates
Table 100. Eli Lilly Company Information
Table 101. Eli Lilly Description and Business Overview
Table 102. Eli Lilly Psychiatric Long-acting Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Eli Lilly Psychiatric Long-acting Injection Product
Table 104. Eli Lilly Recent Developments/Updates
Table 105. Alkermes Company Information
Table 106. Alkermes Description and Business Overview
Table 107. Alkermes Psychiatric Long-acting Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Alkermes Psychiatric Long-acting Injection Product
Table 109. Alkermes Recent Developments/Updates
Table 110. Par Pharmaceutical Company Information
Table 111. Par Pharmaceutical Description and Business Overview
Table 112. Par Pharmaceutical Psychiatric Long-acting Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Par Pharmaceutical Psychiatric Long-acting Injection Product
Table 114. Par Pharmaceutical Recent Developments/Updates
Table 115. AbbVie Company Information
Table 116. AbbVie Description and Business Overview
Table 117. AbbVie Psychiatric Long-acting Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. AbbVie Psychiatric Long-acting Injection Product
Table 119. AbbVie Recent Developments/Updates
Table 120. Luye Pharmaceutical Company Information
Table 121. Luye Pharmaceutical Description and Business Overview
Table 122. Luye Pharmaceutical Psychiatric Long-acting Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Luye Pharmaceutical Psychiatric Long-acting Injection Product
Table 124. Luye Pharmaceutical Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Psychiatric Long-acting Injection Distributors List
Table 128. Psychiatric Long-acting Injection Customers List
Table 129. Psychiatric Long-acting Injection Market Trends
Table 130. Psychiatric Long-acting Injection Market Drivers
Table 131. Psychiatric Long-acting Injection Market Challenges
Table 132. Psychiatric Long-acting Injection Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
Table 136. Authors List of This Report
List of Figures
Figure 1. Product Picture of Psychiatric Long-acting Injection
Figure 2. Global Psychiatric Long-acting Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Psychiatric Long-acting Injection Market Share by Type: 2023 & 2030
Figure 4. Aripiprazole Long-acting Injection Product Picture
Figure 5. Haloperidol Long-acting Injection Product Picture
Figure 6. Paliperidone Long-acting Injection Product Picture
Figure 7. Risperidone Long-acting Injection Product Picture
Figure 8. Olanzapine Long-acting Injection Product Picture
Figure 9. Others Product Picture
Figure 10. Global Psychiatric Long-acting Injection Market Value by Application (2024-2030) & (US$ Million)
Figure 11. Global Psychiatric Long-acting Injection Market Share by Application: 2023 & 2030
Figure 12. Schizophrenia
Figure 13. Bipolar Disorder
Figure 14. Others
Figure 15. Global Psychiatric Long-acting Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Psychiatric Long-acting Injection Market Size (2019-2030) & (US$ Million)
Figure 17. Global Psychiatric Long-acting Injection Sales (2019-2030) & (K Units)
Figure 18. Global Psychiatric Long-acting Injection Average Price (US$/Unit) & (2019-2030)
Figure 19. Psychiatric Long-acting Injection Report Years Considered
Figure 20. Psychiatric Long-acting Injection Sales Share by Manufacturers in 2023
Figure 21. Global Psychiatric Long-acting Injection Revenue Share by Manufacturers in 2023
Figure 22. Global 5 and 10 Largest Psychiatric Long-acting Injection Players: Market Share by Revenue in Psychiatric Long-acting Injection in 2023
Figure 23. Psychiatric Long-acting Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 24. Global Psychiatric Long-acting Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Psychiatric Long-acting Injection Sales Market Share by Country (2019-2030)
Figure 26. North America Psychiatric Long-acting Injection Revenue Market Share by Country (2019-2030)
Figure 27. United States Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Psychiatric Long-acting Injection Sales Market Share by Country (2019-2030)
Figure 30. Europe Psychiatric Long-acting Injection Revenue Market Share by Country (2019-2030)
Figure 31. Germany Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Psychiatric Long-acting Injection Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Psychiatric Long-acting Injection Revenue Market Share by Region (2019-2030)
Figure 38. China Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Psychiatric Long-acting Injection Sales Market Share by Country (2019-2030)
Figure 46. Mexico Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East and Africa Psychiatric Long-acting Injection Sales Market Share by Country (2019-2030)
Figure 51. Middle East and Africa Psychiatric Long-acting Injection Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Psychiatric Long-acting Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Psychiatric Long-acting Injection by Type (2019-2030)
Figure 56. Global Revenue Market Share of Psychiatric Long-acting Injection by Type (2019-2030)
Figure 57. Global Psychiatric Long-acting Injection Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Psychiatric Long-acting Injection by Application (2019-2030)
Figure 59. Global Revenue Market Share of Psychiatric Long-acting Injection by Application (2019-2030)
Figure 60. Global Psychiatric Long-acting Injection Price (US$/Unit) by Application (2019-2030)
Figure 61. Psychiatric Long-acting Injection Value Chain
Figure 62. Psychiatric Long-acting Injection Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
